Home-based transcranial direct current stimulation for the treatment of major depressive disorder
Living with depression can be tough, and current treatments don't work for everyone. This new study is exploring whether a gentle brain stimulation treatment called transcranial direct current stimulation (tDCS) can help. tDCS sends a small, harmless electrical current to the brain, and previous research suggests it might improve depression. This study will involve adults aged 18 and over with depression and will compare whether using tDCS at home, alongside their usual care, is more effective than just usual care. The aim is to make tDCS more accessible and to understand how it can be used in everyday healthcare settings across England and Wales.
At a glance
What is this study about?
If you're living with depression, you'll know that finding effective treatments can be a journey. While many people benefit from antidepressant medications or talking therapies, for some, these don't fully ease their symptoms. Others might prefer not to take medication or attend therapy sessions. This study is exploring a different approach called transcranial direct current stimulation, or tDCS, which is a way to gently stimulate the brain with a small electric current that might help brain cells work better.
Previous research has shown promising results, suggesting that tDCS could help reduce symptoms of depression. We've already conducted studies that looked at whether people could use tDCS safely at home and found that those who received the active tDCS treatment reported more improvements in their depression symptoms compared to those who received an inactive device. This new study builds on that work.
The main goal of this current study is to understand how we can make tDCS available as part of regular care. We want to see if using tDCS at home in addition to your usual depression treatment (like medication or talking therapy) leads to better improvements in your mood and symptoms compared to just continuing with your usual care alone. It's about finding new ways to help people living with depression feel better.
Key takeaways
- This study is testing a home-based brain stimulation treatment (tDCS) for major depression.
- It aims to see if tDCS, when added to usual care, helps improve depressive symptoms more than usual care alone.
- Participation involves either using a tDCS device at home or continuing with your usual care for depression.
- The study lasts up to 10 months, with appointments mostly done remotely.
- Most people will be offered the active tDCS treatment eventually, if they are eligible and want to try it.
- Common side effects (tingling, redness, headache) are usually mild.
Who may be eligible?
This study is for adults aged 18 and over who have been feeling depressed for at least two weeks. You can be taking antidepressant medication or having talking therapy, but you'll need to have been on the same treatment plan for at least six weeks before joining. If you're not currently receiving any treatment for your depression, you can also take part. You must be registered with a GP in England or Wales and be happy for us to contact them about your involvement in the study.
There are some reasons why you might not be able to join. For example, if you have a high risk of suicide or another significant mental health condition (like obsessive-compulsive disorder) that is your main concern. Also, if you use certain medications daily that affect how your brain works, or if you use illicit drugs or have heavy alcohol use, you might not be eligible. If you've had other types of brain stimulation treatments (like ECT or TMS) in the past, or have certain medical or brain conditions (like dementia or implants in your brain), you won't be able to participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Have you been feeling depressed for at least two weeks?
- Are you registered with a GP in England or Wales?
- Are you able to provide consent to take part?
- Have you *not* had other brain stimulation treatments (like ECT or TMS) before?
- Do you *not* have any implants in your brain?
What does participation involve?
If you decide to take part, your involvement in the study is expected to last up to 10 months. This includes some initial checks and then 9 months for the study itself, with a final check-in to see how you're doing.
At the start, you'll be randomly put into one of two groups: either the tDCS group or the 'usual care' group. Being 'randomly allocated' means it's like flipping a coin – you won't get to choose which group you're in. If you're in the usual care group, you'll continue with the treatments your GP or psychiatrist has prescribed for your depression, but you won't receive the tDCS treatment. If you're in the tDCS group, you'll receive the active tDCS treatment in addition to your usual care.
The first part of the study lasts 10 weeks. If you're in the tDCS group, you'll have tDCS sessions for 30 minutes, five times a week for the first three weeks, then three times a week for the next seven weeks, making a total of 36 sessions. You'll do these sessions at home, and for your very first session, a researcher will supervise you either by video call or in person if you prefer and can visit a local research site. We'll have appointments with you during this time at 1, 4, 7, and 10 weeks, and then again at 4 and 6 months after the study starts. Between week 10 and these follow-up visits, the tDCS group can choose to continue with tDCS sessions (3 times a week) if they wish, alongside their usual care.
In the second part of the study, after 6 months, everyone will be offered the active tDCS treatment if they'd like to try it. If you were in the usual care group and your depression hasn't improved, you can start tDCS. If you were already in the tDCS group, you can continue with up to three sessions a week for another three months. We'll then have a final check-up with you 3 months later, which will be 9 months from when you first joined the study. After this, your participation will be complete.
Potential risks and benefits
Locations (6)
- Cardiff and Vale U H BCity onlyCardiff, Wales
- Cumbria, Northumberland, Tyne and Wear NHS Foundation TrustCity onlyNewcastle upon Tyne, England
- Northamptonshire Healthcare NHS Foundation TrustCity onlyKettering, England
- Nottinghamshire Healthcare NHS Foundation TrustCity onlyNottingham, England
- South London and Maudsley NHS Foundation TrustCity onlyBeckenham, England
- Hampshire and Isle of Wight Healthcare NHS Foundation TrustUnverifiedSouthampton, England
Common questions
What is tDCS?
tDCS (transcranial direct current stimulation) is a form of gentle brain stimulation that uses a small electric current to affect how your brain cells work. It's being studied as a potential treatment for depression.
Will I have to travel for this study?
Most of the study activities are designed to be done remotely via video call, so you can take part from anywhere in England or Wales. If you prefer, there's also an option to attend in-person at one of our six research sites.
What if I'm already taking medication for depression?
That's okay! You can still participate if you're taking antidepressant medication or having talking therapy, as long as you've been on the same treatment for at least six weeks.
How long will I be in the study?
Your involvement in the study is expected to last up to 10 months, including initial checks and 9 months of study participation with follow-up appointments.
Will I know if I'm getting the active treatment?
No, initially you won't. This study uses a 'randomised' approach, which means you'll be put into either the tDCS group or the usual care group by chance, like flipping a coin. However, after the first 6 months, everyone will be offered the active tDCS treatment.
How to find out more
Rachel Woodham
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.